Literature DB >> 11788090

Spectrum of mutations in the CFTR gene of patients with classical and atypical forms of cystic fibrosis from southwestern Sweden: identification of 12 novel mutations.

B Strandvik1, E Björck, M Fallström, E Gronowitz, J Thountzouris, A Lindblad, D Markiewicz, J Wahlström, L C Tsui, J Zielenski.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the CFTR gene. The spectrum of CFTR mutations varies between populations and depends on different factors, such as ethnic background and geographical location. The extensive CFTR mutation screening of 129 patients with classical or atypical CF from the south-western region of Sweden revealed the presence of 37 CFTR mutations, including 12 novel alleles. The overall mutation detection rate in this study population was 92%, the highest among all tested regions in Sweden. Eight mutations with a frequency above 1% (DeltaF508, 394delTT, R117C, 3659delC, E60X, 1112delT, R764X, and 621 + 1G --> T) accounted for 78% of CF chromosomes and have been recommended for inclusion in the CFTR mutation screening panel for molecular diagnosis of CF in this region. The multiple occurrence of specific CFTR alleles less common than the predominant DeltaF508 mutation (394delTT, R117C, 3659delC) allowed for genotype-phenotype comparisons and revealed consistent relationships between these mutations and disease severity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11788090     DOI: 10.1089/10906570152742290

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  5 in total

1.  Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice.

Authors:  Birgitta Strandvik; Wanda K O Neal; Mohamed A Ali; Ulf Hammar
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

2.  Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Authors:  Aimee C Walsh; Gilles Rault; Zhanhai Li; Virginie Scotet; Ingrid Duguépéroux; Claude Férec; Michel Roussey; Anita Laxova; Philip M Farrell
Journal:  J Cyst Fibros       Date:  2009-11-18       Impact factor: 5.482

3.  A functional CFTR assay using primary cystic fibrosis intestinal organoids.

Authors:  Johanna F Dekkers; Caroline L Wiegerinck; Hugo R de Jonge; Inez Bronsveld; Hettie M Janssens; Karin M de Winter-de Groot; Arianne M Brandsma; Nienke W M de Jong; Marcel J C Bijvelds; Bob J Scholte; Edward E S Nieuwenhuis; Stieneke van den Brink; Hans Clevers; Cornelis K van der Ent; Sabine Middendorp; Jeffrey M Beekman
Journal:  Nat Med       Date:  2013-06-02       Impact factor: 53.440

4.  Prenatal Ultrasound Suspicion of Cystic Fibrosis in a Multiethnic Population: Is Extensive CFTR Genotyping Needed?

Authors:  Chadia Mekki; Abdel Aissat; Véronique Mirlesse; Sophie Mayer Lacrosniere; Elsa Eche; Annick Le Floch; Sandra Whalen; Cecile Prud'Homme; Christelle Remus; Benoit Funalot; Vanina Castaigne; Pascale Fanen; Alix de Becdelièvre
Journal:  Genes (Basel)       Date:  2021-04-29       Impact factor: 4.096

5.  Cystic Fibrosis Polymorphic Variants in a Russian Population.

Authors:  Anna Kiseleva; Marina Klimushina; Evgeniia Sotnikova; Alexey Meshkov; Oxana Drapkina; Olga Skirko; Mikhail Divashuk; Olga Kurilova; Alexandra Ershova; Eleonora Khlebus; Anastasia Zharikova; Irina Efimova; Maria Pokrovskaya; Petr A Slominsky; Svetlana Shalnova
Journal:  Pharmgenomics Pers Med       Date:  2020-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.